top of page

OVCAR8 Xenograft Model

Rincon Bio offers efficacy studies using the OVCAR8 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Ovarian
Derivation:
High grade serous adenocarcinoma in a 64yo female ovarian cancer patient
Mutations:
CTNNB1, ERBB2, KRAS, TP53
NCI60:
Yes
Weeks from stratification to termination (average):
8

OVCAR8 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the OVCAR8 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page